Introduction to Microfabrication in Vascular Engineering

Vascular tissue engineering aims to create functional blood vessels for treating cardiovascular diseases—the leading cause of death worldwide—and for supporting regeneration of ischemic tissues. Microfabrication, the set of techniques used to pattern and build structures at the micrometer scale, has become central to this effort. By enabling precise control over channel geometry, surface topography, and material composition at scales relevant to capillaries (5–10 µm) and arterioles, microfabrication methods allow researchers to construct biomimetic vascular networks that can be perfused, support endothelial lining, and integrate with host vasculature after implantation.

The field has evolved rapidly from simple two-dimensional channel arrays to complex, multi-scale networks that mimic the hierarchical branching of natural blood vessels. These advances rely on techniques borrowed from the semiconductor industry (photolithography), materials science (electrospinning), and additive manufacturing (3D bioprinting), each offering unique advantages and limitations. This article reviews the key microfabrication techniques driving vascular tissue engineering, recent breakthroughs in their application, remaining challenges, and promising directions for future research.

Key Microfabrication Techniques

Photolithography

Photolithography remains the workhorse for producing high-resolution, planar microchannel networks. In this process, a photosensitive polymer (photoresist) is spin-coated onto a substrate, exposed to ultraviolet light through a mask, and then developed to create a pattern. For vascular engineering, the patterned photoresist serves as a mold for casting elastomeric materials such as polydimethylsiloxane (PDMS). The resulting microfluidic channels can be sealed against a flat surface to form enclosed conduits.

Recent improvements include the use of thick resists (e.g., SU-8) to fabricate channels with heights exceeding 100 µm, enabling better mimicry of small arteries. Researchers have also combined photolithography with sacrificial molding, where a channel template is later dissolved (e.g., using gelatin or alginate) to leave behind a hollow tube in a hydrogel scaffold (Huang et al., 2020). This hybrid approach allows integration of open microchannels within cell-laden hydrogels, facilitating nutrient transport and endothelialization. Despite its resolution advantages (down to ~1 µm), photolithography is limited to essentially 2.5-D structures; generating true three-dimensional branching networks requires multiple alignment steps or layer-by-layer assembly.

Electrospinning

Electrospinning produces nanofibrous mats from polymer solutions under a high-voltage electric field. The fibers—typically 50 nm to 5 µm in diameter—can be collected as random meshes or aligned deposits. For vascular tissue engineering, electrospun scaffolds are employed both as vascular grafts (replacing the native vessel wall) and as sacrificial templates for forming microchannels.

A key advantage of electrospun scaffolds is their high porosity and large surface-to-volume ratio, which promote cell infiltration, extracellular matrix (ECM) deposition, and mass exchange. Recent work has focused on co-electrospinning of multiple materials (e.g., polycaprolactone (PCL) and collagen) to combine mechanical strength with bioactivity. Additionally, researchers have developed electrospun microtubes by collecting fibers on a rotating mandrel; these tubes can then be endothelialized and used as small-diameter vascular grafts (<3 mm inner diameter) (Wang et al., 2020).

For microfabrication of internal channels, electrospun fibers can be incorporated as sacrificial wires: after embedding a PCL microfiber in a hydrogel and then dissolving it with a solvent (e.g., hexafluoroisopropanol), a perfusable channel remains. This method yields channels with rough, fibrous walls that may better support endothelial adhesion compared to smooth PDMS surfaces. However, controlling channel diameter precisely and avoiding fiber residues remain challenges.

3D Bioprinting

3D bioprinting deposits cell-laden bioinks layer by layer to build three-dimensional constructs with spatially defined composition. For vascular applications, multiple printing strategies have emerged:

  • Direct writing of sacrificial inks: A sacrificial material (e.g., Pluronic F127, gelatin, or carbohydrate glass) is printed in a vascular pattern and then removed by dissolution or melting after the construct is crosslinked. This leaves behind hollow channels that can be seeded with endothelial cells (Kolesky et al., 2016).
  • Co-axial printing of tubular structures: A nozzle-in-nozzle setup extrudes a core (often alginate or gelatin) surrounded by a shell (cell-laden hydrogel). After crosslinking, the core can be removed to yield a small-diameter tube. This method enables printing of vessels with diameters from 200 µm to several millimeters and has been used to create perfusable vascular constructs that can be surgically connected to host vessels (Shao et al., 2019).
  • Stereolithography (SLA) and digital light processing (DLP): These light-based methods project a 2D image onto a photosensitive resin, curing each layer in seconds. Recent DLP systems can fabricate vascular networks with resolution down to ~50 µm using biocompatible hydrogels like PEGDA or gelatin methacryloyl (GelMA). The approach is particularly promising for embedding complex, pre-designed vascular trees within bulk constructs.

3D bioprinting offers unparalleled geometric freedom but is limited by the mechanical properties of soft bioinks, cell survival during printing, and the difficulty of printing vessels that are both thin and long without collapsing. Nonetheless, it remains the most versatile technique for generating patient-specific, anatomically branching networks.

Recent Advances and Applications

Multi-Scale and Hierarchical Networks

Natural vascular trees span from large arteries (several mm) to capillaries (~6 µm). Engineering such hierarchical networks requires combining multiple fabrication methods. A notable recent example integrated photolithography for large channels (100–500 µm), sacrificial electrospun fibers for intermediate channels (10–50 µm), and self-assembly of endothelial cells for the capillary plexus (Wang et al., 2019). The resulting construct remained perfusable for weeks in vitro and showed anastomosis with host vessels when implanted in rodent models.

Another approach uses SWIFT (sacrificial writing into functional tissue): a viscous sacrificial ink is extruded through a needle into a compacted cell pellet, forming a branched network. After liquefying the ink, the channels are endothelialized. This method has produced perfusable networks in dense tissues like cardiac patches and liver organoids (Skylar-Scott et al., 2019). The key achievement is maintaining high cell density while providing an embedded vascular tree, which is critical for thick tissue viability.

Integration with Stem Cell Technology

Microfabricated channels serve not only as conduits for fluid flow but also as inductive templates for directing stem cell differentiation. For example, channels coated with gradients of growth factors (e.g., VEGF and Ang-1) can guide endothelial progenitor cells to form vessel-like structures with proper lumenization. Combined with induced pluripotent stem cell (iPSC)-derived endothelial cells, personalized vascular grafts are now within reach. Recent studies have shown that such grafts can be fabricated in less than a week using a 3D-printed sacrificial frame and iPSC-endothelial cells, achieving patency for several months in animal models (Gao et al., 2021).

Organ-on-a-Chip Platforms

Microfabricated vascular networks are at the core of organ-on-a-chip systems, which replicate tissue-level functions for drug testing and disease modeling. For instance, a lung-on-a-chip with a microfluidic channel lined by endothelial cells and an adjacent air chamber lined by epithelial cells has shown that cyclic mechanical stretch can mimic breathing and promote barrier function (Huh et al., 2010). Similar platforms now exist for kidney, liver, and heart, all relying on perfusable microvasculature to maintain tissue viability and enable organ-specific responses.

Challenges and Future Directions

Scalability and Manufacturing Reproducibility

Most microvascular constructs demonstrated to date are handcrafted in academic labs. Translating these methods to clinical-grade manufacturing requires automation, quality control assays for channel patency, and sterile packaging. Electrospinning and photolithography are already industrially scalable, but combining them with bioinks and cell handling remains a bottleneck. The development of bench-top bioprinting platforms with sterile enclosures and automated extrusion systems is addressing this, but throughput is still low.

Long-Term Stability and Mechanical Integrity

Soft hydrogels that mimic native ECM often degrade or lose mechanical strength under continuous perfusion. Acellular vascular grafts made from synthetic polymers (e.g., PCL) have superior burst pressure but lack bioactivity. Researchers are exploring degradable elastomers (e.g., poly(glycerol sebacate) and polyurethane) that can withstand arterial pressures while gradually being replaced by host tissue. Additionally, crosslinking strategies (enzymatic, photo-, or ionic) are being optimized to balance scaffold stiffness with cell viability.

Full Biological Functionality

An ideal engineered vessel should not only conduct blood but also exhibit vasoactive properties—responding to flow changes, releasing nitric oxide, and maintaining a non-thrombogenic lumen. Endothelialization alone is insufficient; the underlying smooth muscle layer must provide contractility. Co-culture systems that layer endothelial and smooth muscle cells onto microfabricated scaffolds are being refined. For example, using bi-axial stretching during culture can align smooth muscle actin fibers circumferentially, mimicking the native media layer. Incorporating pericytes around capillaries is another step toward fully functional microvasculature.

Immune Acceptance and Anastomosis

Even with autologous cells, the implanted construct may trigger foreign body reactions or thrombosis at the surgical connection points. Surface modifications with heparin or perlecan domains can reduce clotting, while immunosuppressing coatings (e.g., hydrogel layers) may prevent capsule formation. Recent advances in in situ vascularization—implanting a porous microfabricated scaffold that recruits host blood vessels—sidestep the need for pre-formed anastomosis, but the ingrown vessels must reach the center of thick constructs before cell death occurs.

Smart Materials and Hybrid Systems

Future directions include responsive materials that change properties under physiological stimuli (pH, temperature, shear stress). For instance, thermoresponsive hydrogels that contract at body temperature could be used to reinforce vessel walls, or shape-memory polymers that self-assemble into tubular structures upon heating. Hybrid systems combining microfabrication with organoid self-organization are also gaining traction: printed macro-scale channels guide bulk perfusion, while embedded vascular organoids spontaneously form capillary networks, connecting the printed channels to the surrounding parenchyma.

Conclusion

Microfabrication techniques have advanced from simple laboratory tools to sophisticated platforms for building vascular tissues with unprecedented architectural control. Photolithography provides high-resolution 2D patterns, electrospinning offers nanofibrous scaffolds with biomimetic ECM-like structure, and 3D bioprinting enables freeform construction of hierarchical networks. Recent integrations of these methods have yielded perfusable, multi-scale constructs that support cell viability and integrate with host vasculature. Despite remaining challenges in scalability, mechanical stability, and full biological functionality, the field is moving steadily toward clinical translation. As hybrid approaches and smart materials mature, microfabricated vascular constructs will play an increasingly important role in regenerative medicine, organ-on-a-chip screening, and ultimately, the replacement of damaged blood vessels.